Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Guang Jer Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6162-500X; OpenAlex author ID A5040269369. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Gomisin G Inhibits Pancreatic Cancer Cell Growth by Promoting YAP Degradation. Last author DOI 10.1002/fsn3.72111↗
  2. Comprehensive analysis identifies AMIGO2 as a potential prognosis biomarker of pancreatic adenocarcinoma. Co-author DOI 10.21037/jgo-2025-7↗
  3. Therapeutic effect of a MUC1-specific monoclonal antibody-drug conjugates against pancreatic cancer model. Co-author DOI 10.1186/s12935-022-02839-w↗
  4. A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model. Co-author DOI 10.2147/ott.s186606↗
  5. A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model. Co-author DOI 10.3390/ijms19072004↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lan Li · 3 shared papers, 2022–2026 · strength 0.69
  2. Haihua Gu · 2 shared papers, 2022–2026 · strength 0.43
  3. Jiawei Cao · 2 shared papers, 2022–2025 · strength 0.40
  4. Hyung‐Joo Kwon · 2 shared papers, 2018 · strength 0.17
  5. Younghee Lee · 2 shared papers, 2018 · strength 0.17
  6. Sangkyu Park · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.